Lack of effect of ustekinumab in treatment of allergic contact dermatitis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Allergic contact dermatitis is a chronic inflammatory T cell mediated disease that can be recalcitrant to existing treatments. Ustekinumab is a monocloncal antibody blocking IL-12 and IL-23, shown to be effective and safe for patients with psoriasis. Despite both IL-12 and IL-23 involvement in contact allergy, the effect of Ustekinumab on allergic contact dermatitis has not been reported.
OriginalsprogEngelsk
TidsskriftContact Dermatitis
Vol/bind65
Udgave nummer4
Sider (fra-til)227-30
Antal sider4
ISSN0105-1873
DOI
StatusUdgivet - 1 okt. 2011

ID: 40179388